Cannabinoids inhibit n- and p/q-type calcium channels in cultured rat hippocampal neurons

Journal of Neurophysiology

Volumn 78, Issue 1, 1997, Pages 43-50

  Twitchell, W ^a   Brown, S ^a   Mackie, K ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CALCIUM CHANNEL; CANNABINOID; CANNABINOID RECEPTOR; OMEGA CONOTOXIN; RIMONABANT;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

EID: 0030746408     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1997.78.1.43     Document Type: Article

References (44)

1. BEAN, B. P. Neurotransmitter inhibition of neuronal calcium channels by changes in channel voltage dependence. Nature Lond. 340: 153-156, 1989.
2. BEKKERS, J. M. AND STEVENS, C. F. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc. Natl. Acad. Sci. USA 88: 7834-7838, 1991.
3. BIDAUT-RUSSELL, M., DEVANE, W. A., AND HOWLETT, A. C. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 55: 21-26, 1990.
4. BOUABOULA, M., POINOT-CHAZEL, C., BOURRIÉ, B., CANAT, X., CALANDRA, B., RINALDI-CARMONA, M., LE-FUR, G., AND CASELLAS, P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312: 637-641, 1995.
5. CAPOGNA, M., GAHWILER, B. H., AND THOMPSON, S. M. Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J. Neurophysiol. 75: 2017-2028, 1996.
6. CAULFIELD, M. P. AND BROWN, D. A. Cannabinoid receptor agonists inhibit Ca currents in NG108-15 neuroblastoma cells via a pertussis-toxin sensitive mechanism. Br. J. Pharmacol. 106: 231-232, 1992.
7. DEADWYLER, S. A., HAMPSON, R. E., Mu, J., WHYTE, A., AND CHILDERS, S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273: 734-743, 1995.
8. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIVSON, D., MANDELBAUM, A., ETINGER, A., AND MECHOULAM, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science Wash. DC 258: 1946-1949, 1992.
9. DEWEY, W. L. Cannabinoid pharmacology. Pharmacol. Rev. 38: 151-178, 1986.
10. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.-C., AND PIOMELLI, D. Formation and inactivation of endogenous cannabinoids in central neurons. Nature Lond. 372: 686-691, 1994.
11. DITTMAN, J. S. AND REGEHER, W. G. Contributions of calcium-dependent and calcium-independent mechanisms to presynaptic inhibition at a cerebellar synapse. J. Neurosci. 16: 1623-1633, 1996.
12. HENRY, D. C. AND CHAVKIN, C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptor in Xenopus oocytes. Neurosci. Lett. 186: 91-94, 1995.
13. HERKENHAM, M., GROEN, B.G.S., LYNN, A. B., DE COSTA, B. R., AND RICHFIELD, E. K. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res. 552: 301-310, 1991a.
14. HERKENHAM, M., LYNN, A. B., DE COSTA, B. R., AND RICHFIELD, E. K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547: 267-274, 1991b.
15. HERKENHAM, M., LYNN, A. B., JOHNSON, M. R., MELVIN, L, S., DE COSTA, B. R., AND RICE, K. C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11: 563-583, 1991c.
16. HILLE, B. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 17: 531-536, 1994.
17. HOLLISTER, L. E. Health aspects of cannabis. Pharmacol. Rev. 38: 1-20, 1986.
18. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29: 307-313, 1986.
19. 2+ channels in freshly dissociated rat hippocampal neurons. J. Neurophysiol. 74: 1028-1036, 1995.
20. LUEBKE, J., DUNLAP, K., AND TURNER, T. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron 11: 895-902, 1993.
21. MACKIE, K., DEVANE, W. A., AND HILLE, B. Anandamide, an endogenous cannabinoid, inhibits N-type calcium currents in N18 cells as a partial agonist. Mol. Pharmacol. 44: 498-503, 1993.
22. MACKIE, K. AND HILLE, B. Cannabinoids inhibit N-type calcium current in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89: 3825-3829, 1992.
23. MACKIE, K., LAI, Y., WESTENBROEK, R., AND MITCHELL, R. Cannabinoids activate an inwardly-rectifying potassium conductance and inhibit Q-type voltage-dependent calcium currents in AtT-20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561, 1995.
24. MATSUDA, L. A., BONNER, T. I., AND LOLAIT, S. J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327: 535-550, 1993.
25. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C., AND BONNER, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature Lond. 346: 561-564, 1990.
26. MECHOULAM, R. (Editor). The pharmacohistory of Cannabis saliva. In: Cannabinoids as Therapeutic Agents. Boca Raton, FL: CRC, 1986, p. 1-20.
27. MUNRO, S., THOMAS, K. L., AND ABU-SHAAR, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature Lond. 365: 61-65, 1993.
28. PACHECO, M. A., CHILDERS, S. R., AND WARD, S. J. Cannabinoid receptor characteristics in rat cerebellar granule cells and NG108-15 cells. Soc. Neurosci. Abstr. 17: 606, 1991.
29. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49: 707-714, 1996.
30. PERTWEE, R. G. Evidence for the existence of cannabinoid receptors. Gen. Pharmacol. 24: 811-824, 1993.
31. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J. C., AND LE FUR, G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
32. ROTH, S. H. Stereospecific presynaptic inhibitory effect of △-9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea-pig. Can. J. Physiol. Pharmacol. 56: 968-975, 1978.
33. SCHOLZ, K. AND MILLER, R. Developmental changes in presynaptic calcium channels coupled to glutamate release in cultured rat hippocampal neurons. J. Neurosci. 15: 4612-4617, 1995.
34. SHEN, M., PISER, T. M., SEYBOLD, V. S., AND THAYER, S. A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16: 4322-4334, 1996.
35. SHEN, M., PISER, T. M., AND THAYER, S. A. Cannabinoid receptor agonists inhibit glutamate synaptic transmission in rat hippocampal cultures. Soc. Neurosci. Abstr. 21: 1569, 1995.
36. SHIRE, D., CARILLON, C., KAGHAD, M., CALANDRA, B., RINALDI-CARMONA, M., FUR, G. L., CAPUT, D., AND FERRARA, P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270: 3726-3731, 1995.
37. SONG, Z.-H. AND BONNER, T. I. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN 55,212-2. Mol. Pharmacol. 49: 891-896, 1996.
38. TAKAHASHI, T. AND MOMIYAMA, A. Different types of calcium channels mediate central synaptic transmission. Nature Lond. 366: 156-158, 1993.
39. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. USA 90: 9518-9522, 1993.
40. WARTMANN, M., CAMPELL, D., SUBRAMANIAN, A., BURSTEIN, S. H., AND DAVIS, R. J. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359: 133-136, 1995.
41. WESTENBROEK, R. E., HELL, J. W., SAKURI, T., SNUTCH, T. P., AND CATTERALL, W. A. Immunocytochemical localization of class A calcium channels in adult rat brain. Soc. Neurosci. Abstr. 19: 392, 1993.
42. WESTENBROEK, R. E., HELL, J. W., WARNER, C., DUBEL, S. J., SNUTCH, T. P., AND CATTERALL, W. A. Biochemical properties and subcellular distribution of a N-type calcium channel alpha 1 subunit. Neuron 9: 1099-1115, 1992.
43. 2+ channels in supporting hippocampal synaptic transmission. Science Wash. DC 264: 107-111, 1994.
44. Wu, L. G. AND SAGGAU, P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12: 1139-1148, 1994.